bromopyruvate has been researched along with Carcinoma, Ovarian Epithelial in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fuxe, J; Johansson, J; Löfstedt, L; Pedersen, AB; Shoshan, M; Wintzell, M | 1 |
1 other study(ies) available for bromopyruvate and Carcinoma, Ovarian Epithelial
Article | Year |
---|---|
Repeated cisplatin treatment can lead to a multiresistant tumor cell population with stem cell features and sensitivity to 3-bromopyruvate.
Topics: Aldehyde Dehydrogenase 1 Family; Antineoplastic Agents; Ascites; Biomarkers, Tumor; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Humans; Hyaluronan Receptors; Isoenzymes; Neoplasms, Glandular and Epithelial; Neoplastic Stem Cells; Ovarian Neoplasms; Proto-Oncogene Proteins c-kit; Pyruvates; Retinal Dehydrogenase | 2012 |